Avidity Biosciences Inc
(RNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 12-2018 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,665 | -11,216 | -15,020 | -920 | 9,990 |
| Depreciation Amortization | 211 | 456 | 1,280 | 840 | 430 |
| Other Working Capital | 19,417 | 671 | 0 | -18,500 | -18,020 |
| Other Operating Activity | 1,431 | 434 | -12,520 | 1,780 | 980 |
| Operating Cash Flow | $13,394 | $-9,655 | $-26,260 | $-16,800 | $-6,620 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -49 | -650 | -460 | -60 |
| Other Investing Activity | 0 | 0 | -350 | -110 | -10 |
| Investing Cash Flow | $-130 | $-49 | $-1,000 | $-570 | $-70 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,458 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,400 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 63 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 5,144 | 450 | -190 | 90 |
| Financing Cash Flow | $18,121 | $5,144 | $450 | $-190 | $90 |
| Exchange Rate Effect | N/A | 0 | -50 | 60 | 10 |
| Beginning Cash Position | 3,090 | 7,650 | 109,110 | 112,800 | 112,690 |
| End Cash Position | 34,475 | 3,090 | 82,240 | 95,290 | 106,100 |
| Net Cash Flow | $31,385 | $-4,560 | $-26,860 | $-17,510 | $-6,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,394 | -9,655 | -26,260 | -16,800 | -6,620 |
| Capital Expenditure | -130 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 13,264 | -9,655 | -26,260 | -16,800 | -6,620 |